Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2018 | 01-2018 | 10-2017 | 07-2017 | 04-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,095,000 | 1,630,000 | 3,022,000 | 1,009,000 | 4,024,000 |
| Depreciation Amortization | 2,644,000 | 1,980,000 | 1,314,000 | 636,000 | 2,917,000 |
| Income taxes - deferred | -919,000 | -1,042,000 | -830,000 | 58,000 | -459,000 |
| Accounts receivable | -275,000 | 19,000 | -68,000 | -88,000 | -75,000 |
| Other Working Capital | -173,000 | 1,230,000 | -1,342,000 | -1,063,000 | 139,000 |
| Other Operating Activity | 312,000 | -171,000 | -452,000 | 185,000 | 334,000 |
| Operating Cash Flow | $4,684,000 | $3,646,000 | $1,644,000 | $737,000 | $6,880,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,027,000 | 581,000 | 669,000 | 356,000 | 985,000 |
| PPE Investments | -1,068,000 | -776,000 | -524,000 | -278,000 | -1,254,000 |
| Net Acquisitions | 5,921,000 | 5,947,000 | 5,982,000 | N/A | -1,324,000 |
| Other Investing Activity | -22,000 | -5,000 | -2,000 | 5,000 | 22,000 |
| Investing Cash Flow | $5,858,000 | $5,747,000 | $6,125,000 | $83,000 | $-1,571,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -249,000 | -391,000 | -190,000 | 569,000 | 906,000 |
| Debt Issued | 21,000 | 21,000 | 20,000 | 18,000 | 2,140,000 |
| Debt Repayment | -7,370,000 | -4,167,000 | -4,161,000 | -8,000 | -863,000 |
| Common Stock Issued | 403,000 | 333,000 | 230,000 | 143,000 | 428,000 |
| Common Stock Repurchased | -2,171,000 | -1,964,000 | -1,888,000 | -1,233,000 | -3,544,000 |
| Dividend Paid | -2,494,000 | -1,870,000 | -1,247,000 | -625,000 | -2,376,000 |
| Other Financing Activity | -94,000 | -88,000 | -41,000 | -5,000 | 26,000 |
| Financing Cash Flow | $-11,954,000 | $-8,126,000 | $-7,277,000 | $-1,141,000 | $-3,283,000 |
| Exchange Rate Effect | 114,000 | 124,000 | 70,000 | 45,000 | 65,000 |
| Beginning Cash Position | 4,967,000 | 4,967,000 | 4,967,000 | 4,967,000 | 2,876,000 |
| End Cash Position | 3,669,000 | 6,358,000 | 5,529,000 | 4,691,000 | 4,967,000 |
| Net Cash Flow | $-1,298,000 | $1,391,000 | $562,000 | $-276,000 | $2,091,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,684,000 | 3,646,000 | 1,644,000 | 737,000 | 6,880,000 |
| Capital Expenditure | -1,068,000 | -776,000 | -524,000 | -278,000 | -1,254,000 |
| Free Cash Flow | 3,616,000 | 2,870,000 | 1,120,000 | 459,000 | 5,626,000 |